4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-009233
EVP & Group Pres, Cardiology sold 132,527 shares at $85.00 ($11,264,888)
- EVP & Group Pres, Cardiology acquired 116,639 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Fitzgerald Joseph Michael · EVP & Group Pres, Cardiology
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +59,021 | $17.26 | $1,018,702 | 235,376 | D |
| 2024-10-07 | Exercise or conversion : show line 2 in the form 10b5-1 | +57,618 | $24.98 | $1,439,298 | 292,994 | D |
| 2024-10-07 | Sale : show line 3 in the form 10b5-1 | −132,527 | $85.00 | $11,264,888 | 160,467 | D |
| Open-market sales · 132,527 sh · avg $85.00 · $11,264,888 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-07 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −59,021 | 0 | D |
| 2024-10-07 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −57,618 | 0 | D |
Loading xslF345X05/doc4.xml…